Olema Oncology, Inc.
5 private offerings reported to the SEC on Form D since 2016, $527.4M sold in all. Pharma, California.
- Form D offerings: 5
- Reported sold: $527.4M
- Newest: Dec 12, 2024
- IPO: Nov 19, 2020 · $209M
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Dec 12, 2024 | — | $250.0M | $250.0M | Olema Pharmaceuticals, Inc.Pharma · California | Not amended | 0001243233-24-000002 |
| Sep 14, 2023 | — | $130.0M | $130.0M | Olema Pharmaceuticals, Inc.Pharma · California | Not amended | 0001243233-23-000003 |
| Oct 13, 2020 | — | $87.4M | $87.4M | Olema Pharmaceuticals, Inc.Pharma · California | Not amended | 0001739074-20-000012 |
| Mar 27, 2020 | — | $53.9M | $55.4M | Olema Pharmaceuticals, Inc.Pharma · California | Jun 23, 2020 | 0001750284-20-000001 |
| Aug 27, 2018 | — | $6.1M | $6.1M | Olema Pharmaceuticals, Inc.Pharma · California | Not amended | 0001750284-18-000001 |
- Ticker
- OLMA
- Business address
- South San Francisco, Ca
- Incorporated in
- Delaware
- SEC industry
- Pharmaceutical Preparations
- Former names
- Olema Pharmaceuticals, Inc.
- All SEC filings
- CIK 1750284 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR